■ Resection, Trans-Arterial Chemoembolization (TACE), and Ablation
|Number||Largest diameter, cm|
*Adjustment of inverse probability of treatment weighing analysis.
†In a hypothetical pseudo-population (median ± standard deviation): 68 ± 9 years old; serum albumin, 3.7 ± 0.5 g/dL; serum total bilirubin, 1.0 ± 0.6; platelet count, 126×103 ± 65×103/μL.
‡Available for largest diameter of hepatocellular carcinoma ≤ 3 cm
Disclaimer: This calculator is not meant to be a substitute for medical opinions by
qualified physicians regarding cancer treatment. Results from this calculator should only be used in conjunction with
all other clinical information in each case.
Further details regarding the development of this tool may be found in the associated publication: Kawaguchi Y, et al. Effect of Diameter and Number of Hepatocellular Carcinomas on Survival After Resection, Transarterial Chemoembolization, and Ablation. American Journal of Gastroenterology 2021;116(8):1698-1708
■ 5-Year Overall Survival Probability